Subject: Re: More Bloomstran On Buybacks...
"What happened to the remaining 1.7%? That's the dilution that comes with CFOs telling investors to ignore share-based compensation because it's not a cash expense."

Yet another reason to own undervalued BRK in lieu of an overvalued S&P 500 in a likely future environment of low equity returns.